title: Hepatitis E masquerading as drug-induced liver injury.
abstract: The patient presented below gives us the opportunity to discuss challenges in the diagnosis of drug-induced liver injury in an era of increasing awareness of hepatitis E.
authors.affiliation: Division of Digestive and Liver Diseases, Department of Internal Medicine, the University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390, USA.
authors.forename: Emerson Y
authors.initials: EY
authors.lastname: Chen
authors.forename: Karl
authors.initials: K
authors.lastname: Baum
authors.forename: William
authors.initials: W
authors.lastname: Collins
authors.forename: Arthur
authors.initials: A
authors.lastname: Löve
authors.forename: Michael
authors.initials: M
authors.lastname: Merz
authors.forename: Sigurdur
authors.initials: S
authors.lastname: Olafsson
authors.forename: Einar S
authors.initials: ES
authors.lastname: Björnsson
authors.forename: William M
authors.initials: WM
authors.lastname: Lee
mesh_terms: D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D003937:Diagnosis, Differential; D000068876:Fingolimod Hydrochloride; D016751:Hepatitis E / Q000097:blood / Q000175:diagnosis* / Q000821:virology; D016752:Hepatitis E virus; D006801:Humans; D008297:Male; D009103:Multiple Sclerosis / Q000188:drug therapy; D011409:Propylene Glycols / Q000627:therapeutic use; D012367:RNA, Viral / Q000097:blood; D013110:Sphingosine / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D011409:Propylene Glycols; D012367:RNA, Viral; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine